← Back to Search

Behavioral Intervention

Control Group: Usual Care for Exclusive Breastfeeding (MILC Trial)

N/A
Waitlist Available
Led By Tony Ma, MS
Research Sponsored by Benten Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Mothers who successfully exclusively breastfed for up to 6 months, at least one child OR mothers who attempted EBF but were unsuccessful at breastfeeding, in the past 3 years
* Self-identify as Hispanic
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month, 3 months and 6 months
Awards & highlights

Summary

The innovative platform MILC is designed to provide an integrated and comprehensive professional and social support network with personalized breastfeeding (BF) education to target exclusive breastfeeding (EBF) and any BF behaviors in low-income Hispanic women. Formative research conducted for the development of MILC and results from pilot testing will help guide the completion of the development and testing of this prototype that specifically caters to Hispanic women. In the long term, MILC has the potential to increase the rates of EBF and any BF up to 12 months.

Who is the study for?
This trial is for low-income Hispanic mothers who are currently breastfeeding or planning to breastfeed. It aims to help them overcome breastfeeding challenges using a mobile app called MILC, which offers professional and social support along with personalized education.
What is being tested?
The study is testing the effectiveness of the MILC application in promoting exclusive and any breastfeeding behaviors compared to usual care methods. The app provides a network of support tailored specifically for Hispanic women.
What are the potential side effects?
Since this trial involves the use of a mobile application rather than medication, there are no direct medical side effects. However, users may experience increased screen time or stress if technical issues arise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month, 3 months and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month, 3 months and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Any breastfeeding rate(EBF)
Exclusive breastfeeding
Secondary study objectives
Emergency department visit (Medical outcomes)
Infant weight (Medical outcomes)
Other study objectives
Acceptance and Adoption
Acculturation
BF history & attitudes questionnaire
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Intervention group: MILC applicationExperimental Treatment1 Intervention
Eligible Hispanic participants in their third trimester will be recruited for the study. The intervention group will receive standard WIC services plus the MILC application.
Group II: Control Group: Usual CareExperimental Treatment1 Intervention
Participants in the control group will receive care as usual with standard breastfeeding services from the WIC program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Usual care
2011
Completed Phase 4
~23770

Find a Location

Who is running the clinical trial?

Temple UniversityOTHER
309 Previous Clinical Trials
87,741 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
403 Previous Clinical Trials
1,345,981 Total Patients Enrolled
Benten Technologies, Inc.Lead Sponsor
3 Previous Clinical Trials
704 Total Patients Enrolled
~119 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top